New hope to stop transplanted kidneys from scarring and failing
NCT ID NCT06751602
Summary
This study is testing if a drug called belumosudil can prevent harmful scarring inside newly transplanted kidneys. The trial will involve 40 people who recently received a kidney transplant. Participants will receive either the study drug or a placebo, in addition to their standard anti-rejection medications, for one year to see if it helps preserve the health of the transplanted organ.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REJECTION CHRONIC RENAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Houston Methodist Research Institute
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.